Developmental Centers for Translational Research on the Clinical Neurobiology of Drug Addiction

The summary for the Developmental Centers for Translational Research on the Clinical Neurobiology of Drug Addiction grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Developmental Centers for Translational Research on the Clinical Neurobiology of Drug Addiction: The National Institute on Drug Abuse (NIDA) invites applications to support the development of translational research centers on the neurobiology of drug abuse that have a strong clinical/human neurobiology focus and the capability to integrate preclinical/animal studies that will serve to directly inform the direction of the clinical research. Advances in the technological armamentarium that can now be brought to bear on questions concerning the acute and chronic effects of drugs of abuse, the factors that influence addiction liability, the neurobiological alterations that may lead to abuse and addiction, and the effects of intrinsic and extrinsic influences on the course of treatment and relapse now make it possible to pose very specific questions on the nature of drug effects in the human nervous system. Despite technical advances, however, the spectrum of approaches that can be used in preclinical investigations renders animal research much more suitable for mechanistic studies of the neurobiology of drug abuse. This funding opportunity announcement is designed to encourage teams of investigators to propose the development of research programs with a primary focus on clearly defined issues in drug abuse and addiction in clinical populations that can simultaneously be investigated in animal models with the aim of, ultimately, using the preclinical findings to refine and direct the clinical research. It is expected that the centers funded through this RFA will be well positioned to compete for funding through a subsequent funding opportunity announcement for larger centers for Translational Research on Drug Addiction.